Approval · Notice of Compliance 21974 · 2019
DIVIGEL: Notice of Compliance 21974
Issued March 15, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21974
- Date
- March 15, 2019
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To add a new package size for samples (boxes of 7 packets)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIVIGEL | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL 0.1 PER